Yan Liu

Affiliations: 
2015 Harvard University, Cambridge, MA, United States 
Google:
"Yan Liu"

Parents

Sign in to add mentor
Shigehisa Kuriyama grad student 2015 Harvard
 (Toxic cures: Poisons and medicines in medieval China)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Wong KK, Liu Y, Li Y, et al. (2017) Gemcitabine and Chk1 inhibitor AZD7762 synergistically suppress the growth of Lkb1-deficient lung adenocarcinoma. Cancer Research
Adeegbe D, Liu Y, Lizotte PH, et al. (2017) Synergistic Immunostimulatory Effects and Therapeutic Benefit of Combined Histone Deacetylase and Bromodomain Inhibition in Non-small Cell Lung Cancer. Cancer Discovery
Zhang H, Qi J, Reyes JM, et al. (2016) Oncogenic deregulation of EZH2 as an opportunity for targeted therapy in lung cancer. Cancer Discovery
Mohammad HP, Smitheman KN, Kamat CD, et al. (2015) A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC. Cancer Cell. 28: 57-69
Smitheman K, Cusan M, Liu Y, et al. (2015) Abstract 3513: Inhibition of LSD1 for the treatment of cancer Cancer Research. 75: 3513-3513
Christensen CL, Kwiatkowski N, Abraham BJ, et al. (2014) Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor. Cancer Cell. 26: 909-22
Liu Y, Marks K, Cowley GS, et al. (2013) Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancer. Cancer Discovery. 3: 870-9
Kruger RG, Mohammad H, Smitheman K, et al. (2013) Inhibition Of LSD1 As a Therapeutic Strategy For The Treatment Of Acute Myeloid Leukemia Blood. 122: 3964-3964
Chen Z, Cheng K, Walton Z, et al. (2012) A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response. Nature. 483: 613-7
Liu Y, Cowley GS, Cohoon TJ, et al. (2012) Abstract LB-260: Identification of DTYMK and CHEK1 as therapeutic targets in LKB1 mutant non-small cell lung cancer Cancer Research. 72
See more...